“…Two studies tested patients off dopaminergic medication [ 26 , 30 ] and three did not report medication status [ 24 , 27 , 32 ]. The study designs were heterogeneous: two studies were open-label (no subject or researcher blinding) [ 28 , 29 ]; three were parallel arm, randomized, double-blind, sham-controlled designs [ 25 , 27 , 32 ]; and four were crossover, randomized, sham-controlled designs, with two being double-blind [ 24 , 26 ], one being single-blind (subject) [ 31 ], and one with unstated blinding [ 30 ]. All but one study administered tDCS with intensities ≤ 2 mA (range of current densities = 0.03 mA/cm 2 – 0.08 mA/cm 2 ) for 15–25 min (mode = 20 min) and targeted frontal brain areas (i.e., the dorsolateral prefrontal cortex (DLPFC), frontal polar area) [ 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 ]; the other study used 2 and 4 mA intensities for 20 min and targeted the cerebellum [ 24 ].…”